School of Medicine

The Latest

New US Academic Alliance for IPCC Opens Critical Nomination Access

A newly established network of U.S. academic institutions including UC San Diego has formed to provide coordinated support for American climate scientists.

Xylazine Detected in U.S.-Mexico Border Drug Supply, Study Finds

Researchers at UC San Diego have confirmed the presence of xylazine in the illicit drug supply at the U.S.-Mexico border. While xylazine remains less common in the Western U.S., border cities serve as key trafficking hubs and may have higher rates of emerging substances.

A device that shows if fentanyl is present.

UC San Diego Team Develops New Dose Prediction Model for Breast Cancer Radiotherapy

Researchers at UC San Diego have developed advanced deep learning techniques that could revolutionize treatment planning for breast cancer radiotherapy – making it faster and improving its quality.

Top view of doctor analyzing breast scans.

Groundbreaking Step in Battling Angioedema at UC San Diego

UC San Diego has established the Hereditary Angioedema (HAE) Community Endowed Chair in Angioedema Clinical Excellence, marking an important milestone in the fight against hereditary angioedema, a rare and potentially life-threatening genetic condition.

Tariq Rana, Ph.D. Appointed Chair of the Department of Cellular and Molecular Medicine

University of California San Diego School of Medicine is pleased to announce that Tariq Rana, Ph.D., Distinguished Professor and chief of the Division of Genetics in the Department of Pediatrics, has been appointed chair of the Department of Cellular and Molecular Medicine.

Could Cutting NIH Funding Delay the Next Alzheimer’s Breakthrough?

After joining Rep. Scott Peters in Washington, D.C., Dr. Jim Brewer, chair of the Department of Neurosciences, is raising concerns about proposed NIH funding cuts. In this Q&A, he explains why sustained federal investment is essential to advancing Alzheimer’s research and more.